Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares ELN 2022: diagnosis and management of acute myeloid leukaemia in adults, ELN 2022 risk classification, VIALE-A, Cytarabine + anthracycline ('7+3') and the tag subtype-page.
Shares Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine, Venetoclax and the tag subtype-page.
Shares Revumenib, Allogeneic stem cell transplantation, Azacitidine, Venetoclax and the tag subtype-page.
Shares Allogeneic stem cell transplantation, Venetoclax and the tag subtype-page.
Shares Allogeneic stem cell transplantation, Minimal / molecular residual disease (MRD) and the tag subtype-page.
Shares Allogeneic stem cell transplantation, Venetoclax and the tag subtype-page.
Shares NGS-based MRD (clonoSEQ and molecular MRD) and the tag subtype-page.
Shares Azacitidine and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.